The immune-related biomarker TEK inhibits the development of clear cell renal cell carcinoma (ccRCC) by regulating AKT phosphorylation.
Siming ChenMengxue YuLingao JuGang WangKaiyu QianYu XiaoXing-Huan WangPublished in: Cancer cell international (2021)
TEK plays an important role in risk assessment and survival prediction for ccRCC patients as a new immune gene and maybe an emerging target for immunotherapy for ccRCC patients.